Mitchell L. Krassan
2015
In 2015, Mitchell L. Krassan earned a total compensation of $1M as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 137% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $76,478 |
---|---|
Option Awards | $720,829 |
Salary | $232,388 |
Other | $11,289 |
Total | $1,040,984 |
Krassan received $720.8K in option awards, accounting for 69% of the total pay in 2015.
Krassan also received $76.5K in non-equity incentive plan, $232.4K in salary and $11.3K in other compensation.
Rankings
In 2015, Mitchell L. Krassan's compensation ranked 7,756th out of 13,638 executives tracked by ExecPay. In other words, Krassan earned more than 43.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,756 out of 13,638 | 43rd |
Division Manufacturing | 2,941 out of 5,190 | 43rd |
Major group Chemicals And Allied Products | 1,059 out of 1,854 | 43rd |
Industry group Drugs | 854 out of 1,528 | 44th |
Industry Pharmaceutical Preparations | 673 out of 1,182 | 43rd |
Source: SEC filing on April 25, 2017.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2015.